B
B

BayerAG

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

From ashes to fly larvae, new ideas aim to revive farm soil

FOCUS-From ashes to fly larvae, new ideas aim to revive farm soil By Rod Nickel WINNIPEG, Manitoba, Jan 30 (Reuters) - As extreme weather and human activity degrade the world's arable land, scientists and developers are looking at new and largely unproven methods to save soil for agriculture. One company is injecting liquid clay into California desert to trap moisture and help fruit to grow, while another in Malaysia boosts soil with droppings from fly larvae.
B

Bayer investor calls for swift replacement of newspaper

Bayer investor calls for swift replacement of CEO -newspaper FRANKFURT, Jan 28 (Reuters) - Bayer BAYGn.DE investor Deka has called for CEO Werner Baumann to be replaced ahead of his scheduled departure, adding to mounting pressure on the German drugmaker. "Bayer needs a new strategic positioning, which cannot be credibly accomplished under Werner Baumann," Ingo Speich, head of sustainability and corporate governance at Deka, told the Frankfurter Allgemeine Sonntagszeitung (FAS) newspaper in rema
B

Bayer AG: CHMP Recommends Bayer's Darolutamide For Treatment Of Metastatic Hormone-Sensitive Prostate Cancer

BRIEF-Bayer AG: CHMP Recommends Bayer's Darolutamide For Treatment Of Metastatic Hormone-Sensitive Prostate Cancer Jan 27 (Reuters) - Bayer AG BAYGn.DE : CHMP RECOMMENDS BAYER'S DAROLUTAMIDE FOR TREATMENT OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER Source text: https://bit.ly/3WJoMoy Further company coverage: BAYGn.DE Reporting by Paul Carrel
B

EU to aggregate cancer imaging data across bloc in new project

UPDATE 1-EU to aggregate cancer imaging data across bloc in new project Adds comments by Philips, Healthineers By Maggie Fick and Ludwig Burger Jan 23 (Reuters) - The European Union on Monday launched a project to collect and aggregate cancer imaging data in an effort to speed up innovation and early cancer diagnosis using artificial intelligence.
B
P
S

EU to aggregate cancer imaging data across bloc in new project

EU to aggregate cancer imaging data across bloc in new project Jan 23 (Reuters) - The European Union on Monday launched a project to collect and aggregate cancer imaging data in an effort to speed up innovation and early cancer diagnosis using artificial intelligence. The new European Cancer Imaging Initiative will give clinicians, researchers and innovators "easy access to large amounts of cancer imaging data", the European Commission said in a statement.
B
P
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.